Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

This study is looking for women newly diagnosed with certain advanced stages of cervical or vaginal cancer. This includes specific types like squamous cell, adenocarcinoma, or adenosquamous carcinoma, and the cancer shouldn't be treatable by surgery alone. Doctors will check if your cancer has spread to nearby lymph nodes in your abdomen using a special scan, and if it has, you might not be able to join.

To be considered, you'll need to be generally well enough to take part in the study activities, as determined by your doctors. Your blood tests, liver function, and kidney function will need to be within a healthy range, as these are important for receiving chemotherapy safely. You should also have a good estimated life expectancy.

There are also a few things that would mean you couldn't join. For example, if you have diabetes that isn't under control, or if cancer has spread to your brain. You also can't be part of the study if you have HIV and are on certain medications, due to potential interactions.

If you decide to take part, you'll be put into one of two groups by chance (like flipping a coin). One group will receive the standard treatment: radiation therapy and the chemotherapy drug cisplatin. The other group will receive radiation therapy, cisplatin, and the new drug, Triapine.

Your treatment will involve regular visits for radiation therapy. This might include different types of radiation, such as external beams or internal radiation called brachytherapy. You'll also receive cisplatin, likely through an IV, and if you're in the Triapine group, you'll receive that as well.

Throughout the study, you'll have various tests, including blood samples to check your health and how the treatment is affecting you, and special scans to monitor your cancer. Doctors will be very careful to monitor any side effects you might experience. The total duration of your active treatment period will depend on your specific cancer and how you respond, followed by regular check-ups to see how you're doing in the long term.